Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $9.55 in the prior trading day, Astria Therapeutics Inc (NASDAQ: ATXS) closed at $9.36, down -1.99%. In other words, the price has decreased by -$1.99 from its previous closing price. On the day, 0.58 million shares were traded. ATXS stock price reached its highest trading level at $9.8 during the session, while it also had its lowest trading level at $9.19.
Ratios:
Our goal is to gain a better understanding of ATXS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.38 and its Current Ratio is at 22.38. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on July 29, 2024, initiated with a Buy rating and assigned the stock a target price of $35.
On March 28, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’24 when Morabito Christopher sold 10,000 shares for $13.59 per share. The transaction valued at 135,939 led to the insider holds 0 shares of the business.
PERCEPTIVE ADVISORS LLC bought 2,481,350 shares of ATXS for $29,999,522 on Feb 01 ’24. The Director now owns 4,873,721 shares after completing the transaction at $12.09 per share. On Jan 29 ’24, another insider, Morabito Christopher, who serves as the Chief Medical Officer of the company, sold 9,200 shares for $11.15 each. As a result, the insider received 102,552 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXS now has a Market Capitalization of 528224096 and an Enterprise Value of 297878496.
Stock Price History:
Over the past 52 weeks, ATXS has reached a high of $16.90, while it has fallen to a 52-week low of $5.84. The 50-Day Moving Average of the stock is -12.73%, while the 200-Day Moving Average is calculated to be -14.32%.
Shares Statistics:
The stock has traded on average 335.36K shares per day over the past 3-months and 398240 shares per day over the last 10 days, according to various share statistics. A total of 56.43M shares are outstanding, with a floating share count of 48.26M. Insiders hold about 14.49% of the company’s shares, while institutions hold 87.20% stake in the company. Shares short for ATXS as of 1732838400 were 3145785 with a Short Ratio of 9.38, compared to 1730332800 on 3540751. Therefore, it implies a Short% of Shares Outstanding of 3145785 and a Short% of Float of 5.79.
